Page 51 - Vibrational Spectroscopic Imaging for Biomedical Applications
P. 51

28    Cha pte r  O n e


        40.  H. Fabian, N. Thi, M. Eiden, P. Lasch, J. Schmitt, and D. Naumann, “Diagnosing
           Benign and Malignant Lesions in Breast Tissue Sections by Using IR-
           Microspectroscopy,” Biochimica et Biophysica Acta, 1758(7):874–882, 2006.
        41.  R. Dukor, G. Story, and C. Marcott, “Comparison of FT-IR Microspectroscopy
           Methods for Analysis of Breast Tissue Samples,” Institute of Physics Conference
           Series, 165:79–80, 2000.
        42. R.  Bhargava, D. Fernandez, S. Hewitt, and I. Levin “High Throughput
           Assessment of Cells and Tissues: Bayesian Classification of Spectral Metrics
           from Infrared Vibrational Spectroscopic Imaging Data,” Biochimica et Biophysica
           Acta, 1758(7):830–845, 2006.
        43. R.  Bhargava, “Towards a Practical Fourier Transform Infrared Chemical
           Imaging Protocol for Cancer Histopathology,”  Analytical and Bioanalytical
           Chemistry, 389(4):830–845, 2007.
        44.  J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton,
           J. Torhorst, M. J. Mihatsch, G. Sauter, and O. P. Kallioniemi “Tissue Microarrays
           for High-Throughput Molecular Profiling of Tumor Specimens,”  Nature
           Medicine, 4(7):844–847, 1998.
        45.  D. Fernandez, R. Bhargava, S. Hewitt, and I. Levin, “Infrared Spectroscopic
           Imaging for Histopathologic Recognition,” Nature Biotechnology, 23(4):469–474,
           2005.
        46. F. Keith, R. Kong, A. Pryia, and R. Bhargava, “Data Processing for Tissue
           Histopathology Using Fourier Transform Infrared Spectra,” Proceedings of the
           Asilomar Conference on Systems, Signals, and Computers, 71–75, 2006.
        47. P. Rosen, Rosen’s Breast Pathology, 2d ed., pp. 4–5, Lippincott, Williams, and
           Wilkins, Philadelphia, Pa. 2001.
        48.  D. S. May and  N. E. Stroup,“The Incidence of Sarcomas of the Breast among
           Women in the United States, 1973–1986,” Plastic and Reconstructive Surgery,
           87(1):193–194, 1991.
        49. T.  Tlsty and L. Coussens, “Tumor Stroma and Regulation of Cancer
           Development,” Annual Review of Pathology: Mechanisms of Disease, 1:119–150,
           2006.
        50.  R. Salzer, G. Steiner, H. Mantsch, J. Mansfield, and E. Lewis, “Infrared and
           Ramen Imaging of Biological and Biomimetric Samples,” Frensenius Journal of
           Analytical Chemistry, 366:712–726, 2000.
        51.  X. Llora, A. Priya, R. Bhargava, “Observer-Invariant Histopathology using
           Genetics-Based Machine Learning,” Nat. Computing, 8:101–120, 2009.
        52. G.  Van  Belle,  L. D. Fisher, P. J. Heagerty, and T. Lumley,  Biostatistics: A
           Methodology for the Health Sciences, 2d ed., John Wiley & Sons, Hoboken, N. J.,
           2004.
        53.  J. A. Hanley and B. J. McNeil, “The Meaning and Use of the Area under a
           Receiver Operating Characteristic (ROC) Curve,” Diagnostic Radiology, 143(1):
           29–36, 1982.
   46   47   48   49   50   51   52   53   54   55   56